Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

April 26, 2017invest mdr-tb multidrug-resistant Programmes second-line treatments tuberculosis

0

Posted

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

1 Answer

0

Posted

[Int J Tuberc Lung Dis. 2001] Review Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?Gupta R, Raviglione MC, Espinal MA. Int J Tuberc Lung Dis. 2001 Dec; 5(12):1078-9. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes. [Euro Surveill. 2006] Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.Leimane V, Leimans J. Euro Surveill. 2006; 11(3):29-33. Review Programmes and principles in treatment of multidrug-resistant tuberculosis. [Lancet. 2004] Review Programmes and principles in treatment of multidrug-resistant tuberculosis.Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, et al. Lancet. 2004 Feb 7; 363(9407):474-81. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool. [Int J Tuberc Lung Dis. 2009] Development of a standardised multidrug-resistant/extensively drug